Sort
23,748 grants matching “melanoma”
IMMUNOLOGIC CONTROL OF MELANOMA PULMONARY METASTASIS
$205,753University Of Texas Md Anderson Can Ctr · R01 · FY2000 · CA
A zebrafish model for studying orbital development and disease
$205,740Alon Kahana · University Of Michigan At Ann Arbor · K08 · FY2010 · EY
Neuroprotection by MC1R as the basis for the melanoma-Parkinson's disease link
$205,660Xiqun Chen · Massachusetts General Hospital · R21 · FY2016 · NS
P38 MAP Kinase/P1-3 Kinase for Chemoprevention of Cancer
$205,643University Of Arizona · P01 · FY2005 · CA
PSGL-1 mechanisms of T cell exhaustion
$205,525Roberto Tinoco · University Of California-Irvine · R01 · FY2020 · AI
Assessing Resident Physician Melanoma Detection Across Ethnic Groups
$205,481Claudia Hernandez · University Of Illinois At Chicago · R21 · FY2013 · CA
Admin Core
$205,420David E Fisher · Massachusetts General Hospital · P01 · FY2025 · CA
Molecular regulation in reproduction
$205,373Frank S French · Univ Of North Carolina Chapel Hill · U54 · FY2009 · HD
Clinical Research
$205,362Raymond P Perez · Dartmouth College · P30 · FY2007 · CA
IMPACT OF IMMUNE SUPPRESSION ON TCR-TRANSDUCED T CELLS FOR ADOPTIVE
$205,254Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Genomics Shared Resource
$205,228Louise C Showe · Wistar Institute · P30 · FY2020 · CA
Targeting of mTOR Activity for Chemoprevention of Solar UV-induced Skin Cancer
$205,226Timothy Bowden · University Of Arizona · P01 · FY2014 · CA
Admin Core
$205,202David E Fisher · Massachusetts General Hospital · P01 · FY2024 · CA
NEAR INFRARED IMAGING OF MMP-2/MM-9 WITH A HIGHLY SPECIFIC OPTICAL PROBE
$205,200Wilson Barry Edwards · Washington University · R21 · FY2008 · CA
DNA-modulated release of drug from melanoma targeting NP
$205,200Kit S Lam · University Of California At Davis · R21 · FY2009 · CA
Nanoparticles for In Vivo Labeling of T Cells During Cancer Immunotherapy
$205,144Carlos M Rinaldi-Ramos · University Of Florida · R21 · FY2022 · CA
Phase I and Biological Studies of DB67 - A Blood Stable Camptothecin
$205,100Markos Leggas · University Of Kentucky · R21 · FY2008 · CA
Phase I and Biological Studies of DB67 - A Blood Stable Camptothecin
$205,100Markos Leggas · University Of Kentucky · R21 · FY2007 · CA
Effects of silencing RNAs for gastrin and CCK on human pancreatic cancer
$205,100Jill P Smith · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2008 · CA
Administration, Evaluation and Planning Core
$205,099Thomas S. Kupper · Brigham And Women'S Hospital · P50 · FY2009 · CA
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling
$205,078Jing Chen · Emory University · R01 · FY2019 · CA
A genomewide discovery of chemoresistance-associated noncoding RNAs in human cancers
$205,067Tong-Chuan He · University Of Chicago · R21 · FY2019 · CA
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
$205,000Abraham P Lee · University Of California-Irvine · R33 · FY2024 · CA
Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)
$205,000Charles George Eberhart · Johns Hopkins University · R21 · FY2009 · AT
Identification of BATF function and targets during NK cell activation
$205,000Barbara Lynne Kee · University Of Chicago · R21 · FY2021 · AI